3 hrs ago | Tyler Morning Telegraph
Man Crashes Truck Into Lufkin Hospital Office
A man who had been escorted out of a hospital office building was arrested after authorities say he came back and rammed his pickup truck through a plate glass window next to the Memorial Health System of East ...
7 hrs ago | SF Gate
Eli Lilly settles Zyprexa inquiries in 32 states
Eli Lilly & Co. said Tuesday it will pay $62 million to resolve investigations into the marketing and promotion of its antipsychotic drug Zyprexa in 32 states and Washington, D.C. The payments will be divided ...
11 hrs ago | Hampton Roads, Virginia, news, sports...
Ex-hospital executive convicted, another acquitted of buying the influence of RI lawmaker
A federal jury deliberated over five days before finding Robert Urciuoli, the former president and chief executive of Roger Williams Medical Center in Providence, guilty of bribing former state Sen.
15 hrs ago | WUSA9.com Washington, DC
Newborn's Body Found In Trash Bin
Baltimore police say officers found the body of a newborn in a trash bin behind a church after a woman who checked herself into a hospital told doctors she had given birth to a stillborn boy.
Using a fan during sleep lowers SIDS risk by 72 percent
Infants who slept in a bedroom with a fan ventilating the air had a 72 percent lower risk of Sudden Infant Death Syndrome compared to infants who slept in a bedroom without a fan, according to a new study by ...
Dendreon Shares Soar on Provenge Data
Investors focused on the promising Provenge survival data Monday morning and looked past the disappointment that Dendreon would be unable to seek early approval for the experimental cancer vaccine.
J biologic Crohn's disease drug outperforms standard immune-damping pill in company study
Run by J&J's biotech unit, Centocor Inc. , and funded by the company, the study showed that patients getting its Remicade, either alone or in combination with azathioprine pills, brought disease remission in ...
Reuters
|
Reuters
Two drugs don't boost lung cancer survival: Roche
By Emma Thomasson and Ben Hirschler
ZURICH/LONDON (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
Both drugs are targeted therapies -- modern medicines which act as "smart bombs" by crippling cancer cells while leaving healthy cells intact. It had been hoped that adding them together would extend patients' lives.
Roche and Genentech said on Monday a Phase III study investigated the addition of Avastin to Tarceva compared with Tarceva alone for the treatment of patients with advanced non-small cell lung cancer, the most common form of lung cancer.
Nearly one in four Americans believe vaccines cause autism, even though no scientific evidence supports the link.
Cardinal Health Inc., Agrees to Pay $34 Million to Settle Claims That ...
Cardinal Health Inc., one of the nation's largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain ...
Customer Interaction Solutions
Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines
LEIDEN, NETHERLANDS, October 3 / MARKET WIRE/ -- Dutch biopharma company Crucell N.V. today announced that it received a National Institutes of Allergy and Infectious Diseases /National Institutes of Health ...
Jubilant Organosys and Lilly to form JV
Jubilant Organosys and Eli Lilly and Company on Friday announced the formation of an equally owned joint venture in India focussed on providing drug development services exclusively to molecules partnered by ...
Mercy Medical At Rogers Laying Off 41 Workers
Mercy Health System says the outpatient therapy section of Mercy Medical Center at Rogers will be closed and 41 full-time workers laid off.
Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
SCHLIEREN/BASEL, Switzerland & SOUTH SAN FRANCISCO, Calif. - Genentech, Inc. , GlycArt, a company wholly-owned by Roche, and Roche have entered into a collaboration agreement, including a license from GlycArt ...
No verdict yet in case against 2 former executives of Roger Williams Medical Center
The jury in the corruption trial of two ex-Roger Williams Medical Center executives recessed yesterday for the third day without reaching a verdict.
State Gets Funds to Study Children's Health
Michigan is getting $57 million from the National Institutes of Health to expand its role in a research project to study children's health.
Experts: Virgin Mary image may be mineral deposit
The power of prayer extended into day four at Mercy Medical Center. The faithful continued to flock to see what many believe is the Virgin Mary appearing in a window.
Third patient testing positive for Legionnaires' disease dies in New Bruns.
A third patient who was identified as one of the eight positive cases in a Legionnaires' disease outbreak at Saint Peter's University Hospital has died.
Site Picked in Health Major Study
Benton County will serve as a study center in a far-ranging national assessment of children's health, and Arkansas Children's Hospital is getting a $14 million grant to help in the survey.
Vitamin C may limit cancer treatment
Cancer patients should be extremely cautious about popping supplements - the pills may interfere with their medical treatment.